Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

Those data centers that are equipped to handle AI processing loads are projected to require $5.2 trillion in capital ...

Takeda Pharmaceutical Co Ltd (TSE:4502) is set to release its Q4 2024 earnings on May 8, 2025. The consensus estimate for Q4 ...

Dan Gandor, an omnichannel ace who has spent his entire career on the client side of the business, has joined Eversana ...

TOKYO -- Japanese drugmaker Takeda Pharmaceuticals will invest $30 billion in the U.S. over the next five years, CEO ...

Christophe Weber, CEO of Takeda Pharma, discusses the group's plans to invest $30 billion into its U.S. operations over the ...

Q4 2024 Earnings Call Transcript May 9, 2025 Christopher O’Reilly: Thank you very much for taking time out of their busy ...

Japanese pharma major Takeda (TYO: 4502) announced that the US Food and Drug Administration (FDA) has accepted for priority ...

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

Investors might want to bet on Takeda Pharmaceutical Co. (TAK), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Takeda was scrambling to accommodate for rapidly sinking profits from the hasty decline of ADHD mainstay Vyvanse with a 140 ...